Safety of osteoanabolic therapy: a decade of experience

J Bone Miner Res. 2012 Dec;27(12):2419-28. doi: 10.1002/jbmr.1800.

Authors

Cristiana Cipriani¹, Dinaz Irani, John P Bilezikian

Affiliation

¹ Metabolic Bone Diseases Unit, Division of Endocrinology, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.

PMID: 23165426
DOI: 10.1002/jbmr.1800

No abstract available

MeSH terms

Anabolic Agents / therapeutic use*
Animals
Bone and Bones / metabolism
Calcium / urine
Clinical Trials as Topic
Female
Fracture Healing / drug effects
Fractures, Bone / prevention & control*
Glucocorticoids / adverse effects
Humans
Hypoparathyroidism
Male
Osteoporosis / chemically induced
Osteoporosis / drug therapy
Osteosarcoma / chemically induced
Parathyroid Hormone / adverse effects
Parathyroid Hormone / therapeutic use*
Rats
Rats, Inbred F344
Teriparatide / adverse effects
Teriparatide / therapeutic use*

Substances

Anabolic Agents
Glucocorticoids
Parathyroid Hormone
Teriparatide
Calcium